Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc.（GLUE）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
glue · 股价预测 · 9 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 9 位华尔街分析师
Buy
9 位分析师
共识
评级分布
12 个月目标价
High
$37.00
Consensus
$31.75
+88.7% upside
Low
$22.00
Median: $34 · Last Close: $16.83
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$31.75
88.7% upside
High Target
$37
119.9%
Low Target
$22
30.7%
Current Price
$16.83
as of today
Based on analyst price targets, the GLUE stock price prediction for the next 12 months ranges from $22 to $37. The consensus GLUE price forecast of $31.75 implies 88.7% upside from the current price of $16.83.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $16.00 | ↓ 4.92% |
1-day model range: $15.9–$16.1. Peak: $16.1 (-4.92%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · GLUE · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-11 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-03-18 | Guggenheim | Maintains | Buy→Buy |
| 2026-03-18 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-01-14 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-01-08 | Guggenheim | Maintains | Buy→Buy |
| 2026-01-08 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-12-16 | Wells Fargo | Upgrade ↑ | Equal Weight→Overweight |
| 2025-11-07 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2025-03-21 | Wedbush | Maintains | Outperform→Outperform |
| 2025-03-21 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
Wall Street analysts have recently issued updated ratings on Monte Rosa Therapeutics, Inc. (GLUE) stock. Of the recent 30 rating actions, 2 were upgrades and 1 were downgrades. 9 analysts currently cover GLUE.
分析师推荐趋势
GLUE analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$44M
↑ 99.8% YoY
Revenue Next Year
$58M
↑ 30.9% YoY
EPS This Year
$-1.66
EPS Next Year
$-1.84
↑ 10.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast GLUE EPS of $-1.66 for the current fiscal year, based on estimates from 5 analysts. The GLUE revenue forecast is $44M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
GLUE 股价预测由两类独立数据源支撑：来自 9 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。GLUE 的共识目标价为 $31.75（+88.7% 上行空间），分析师共识为 Buy。
GLUE 的短期预测（明日）为 $16.00（-4.92%）。
Monte Rosa Therapeutics, Inc. 在 NASDAQ 上市，代码 GLUE。GLUE 在 2027 年的整体展望偏积极，在覆盖分析师中约 78% 对应 Buy 共识。
常见问题
GLUE 预测 · 8 个问题根据 9 位华尔街分析师，GLUE 的 12 个月平均目标价为 $31.75，最高 $37.00、最低 $22.00。若有图表，中位目标价可在上方查看。相对当前价 $16.83，隐含约 +88.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.